USFDA designates Zydus’ Usnoflast an orphan drug for ALS treatment
Usnoflast (ZYIL1) is a novel, oral small-molecule NLRP3 inhibitor. It has been studied in several pre-clinical models of…
Recover your password.
A password will be e-mailed to you.